Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.34 |
| ▸ | F2 | P00734 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9532708 | 0.86 | NISCH (0.33) | — | |
| SCHEMBL5265951 | 0.72 | POLB (0.44) | SIGMAR1HTR2C | |
| SCHEMBL9868832 | 0.70 | SIGMAR1 (0.39) | SIGMAR1F2HTR2C | |
| Hydrochloric Acid SCHEMBL6586236 | 0.70 | HTR2C (0.41) | SIGMAR1F2HTR2C | |
| SCHEMBL6648602 | 0.69 | SIGMAR1 (0.36) | SIGMAR1F2HTR2C | |
| SCHEMBL10857841 | 0.68 | TUBB4A (0.36) | F2HTR2C | |
| SCHEMBL6368536 | 0.68 | SIGMAR1 (0.34) | SIGMAR1F2HTR2C | |
| SCHEMBL9175105 | 0.67 | CYP1A2 (0.38) | SIGMAR1F2HTR2C | |
| SCHEMBL7808380 | 0.67 | DRD2 (0.48) | SIGMAR1HTR2C | |
| SCHEMBL6648243 | 0.67 | SIGMAR1 (0.36) | SIGMAR1F2HTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0556342-A1 | NEW 1-AZABICYCLOALKANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESS FOR PREPARING SAME | GYOGYSZERKUTATO INTEZET K.V. (HU) | 1993-08-25 | — | — | EP | disclosed |
| WO-1992007854-A1 | NEW 1-AZABICYCLOALKANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESS FOR PREPARING SAME | GYÓGYSZERKUTATÓ INTÉZET KV. (HU) | 1992-05-14 | — | — | WO | disclosed |